QSAR model based on SMILES of inhibitory rate of 2, 3-diarylpropenoic acids on AKR1C3

被引:26
|
作者
Li, Qian [1 ]
Ding, Xiao [1 ]
Si, Hongzong [2 ]
Gao, Hua [1 ]
机构
[1] Qingdao Univ, Pharmaceut Coll, Qingdao 266071, Shandong, Peoples R China
[2] Qingdao Univ, Growing Base State Key Lab, Lab New Fibrous Mat & Modern Text, Inst Computat Sci & Engn, Qingdao 266071, Shandong, Peoples R China
关键词
2; 3-diarylpropenoic acids; AKR1C3; inhibitor; SMILES; CORAL; QSAR; KETO REDUCTASE AKR1C3; SELECTIVE INHIBITORS; DERIVATIVES; POTENT; LEADS;
D O I
10.1016/j.chemolab.2014.09.013
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
In order to study inhibitory effect of 2, 3-diarylpropenoic acids on AKR1C3 (Aldo-keto reductase family 1 member C3), a new QSAR model based on SMILES has been built up. The descriptors of 42 compounds were calculated by CORAL software, and the Monte Carlo method was used to get the best model. The robustness of this model has been tested by Y-scrambling, Leave-one-out (LOO) cross validation and bootstrap resampling. The satisfaction model (n = 32, R-2 = 0.9394, Q(2) = 0.9328, s = 7.59, F = 465 for training set; n = 10, R2 = 0.9410, Q(2) = 0,9064,s = 8.98, F = 127 for test set) was constructed which showed the relationship between the molecular SMILES and the inhibitory rate of 2, 3-diarylpropenoic acids on AKR1C3. This model we obtained will be helpful to find more effective AKR1C3 inhibitors. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:132 / 138
页数:7
相关论文
共 50 条
  • [1] 2,3-Diarylpropenoic acids as selective non-steroidal inhibitors of type-5 17β-hydroxysteroid dehydrogenase (AKR1C3)
    Gazvoda, Martin
    Beranic, Natasa
    Turk, Samo
    Burja, Bojan
    Kocevar, Marijan
    Rizner, Tea Lanisnik
    Gobec, Stanislav
    Polanc, Slovenko
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 62 : 89 - 97
  • [2] AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids
    Skarydova, Lucie
    Zivna, Lucie
    Xiong, Guangming
    Maser, Edmund
    Wsol, Vladimir
    CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 178 (1-3) : 138 - 144
  • [3] Roles of AKR1C3 in malignancy
    Xiao Xin-Zhu
    Lin Li-Ying
    Zhuang Ming-Kai
    Zhong Can-Mei
    Chen Feng-Lin
    中华医学杂志英文版, 2021, 134 (09) : 1052 - 1054
  • [4] Roles of AKR1C3 in malignancy
    Xiao, Xin-Zhu
    Lin, Li-Ying
    Zhuang, Ming-Kai
    Zhong, Can-Mei
    Chen, Feng-Lin
    CHINESE MEDICAL JOURNAL, 2021, 134 (09) : 1052 - 1054
  • [5] Analysis of tissue specific expression of aldo-keto redactases AKR1C3 and AKR1C3
    Hirakawa, Haruka
    Sawada, Hiroshi
    Takikawa, Shin-ichirou
    Hara, Akira
    Iino, Teruhiko
    ZOOLOGICAL SCIENCE, 2006, 23 (12) : 1208 - 1208
  • [6] In vitro CAPE inhibitory activity towards human AKR1C3 and the molecular basis
    Li, Cuiyun
    Zhao, Yining
    Zheng, Xuehua
    Zhang, Hong
    Zhang, Liping
    Chen, Yunyun
    Li, Qing
    Hu, Xiaopeng
    CHEMICO-BIOLOGICAL INTERACTIONS, 2016, 253 : 60 - 65
  • [7] Association of AKR1C3 Polymorphisms with Bladder Cancer
    Tiryakioglu, N. Ozan
    Tunali, Nagehan Ersoy
    UROLOGY JOURNAL, 2016, 13 (02) : 2615 - 2621
  • [8] Structure of AKR1C3 with 3-phenoxybenzoic acid bound
    Jackson, Victoria J.
    Yosaatmadja, Yuliana
    Flanagan, Jack U.
    Squire, Christopher J.
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2012, 68 : 409 - 413
  • [9] Interpretable SMILES-based QSAR Model of Inhibitory Activity of Sirtuins 1 and 2
    Worachartcheewan, Apilak
    Toropova, Alla P.
    Toropov, Andrey A.
    Pratiwi, Reny
    Prachayasittikul, Virapong
    Nantasenamat, Chanin
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2021, 24 (08) : 1217 - 1228
  • [10] AI Based Discovery of a New AKR1C3 Inhibitor for Anticancer Applications
    Pippione, Agnese C.
    Vigato, Chiara
    Tucciarello, Cristina
    Hussain, Samrina
    Salladini, Edoardo
    Truong, Ha H.
    Henriksen, Niel M.
    Vanzetti, Gaia
    Giordano, Giorgia
    Zonari, Daniele
    Mirza, Osman Asghar
    Frydenvang, Karla
    Pignochino, Ymera
    Oliaro-Bosso, Simonetta
    Boschi, Donatella
    Lolli, Marco L.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (08): : 1269 - 1278